Study #ALLIANCEAFT-25
Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) for Low Risk DCIS: A Phase III Prospective Randomized Trial
MD Anderson Study Status
Not Accepting
Treatment Agent
Description
This study looks at the risks and benefits of active monitoring (AM) compared to surgery in the setting of a pragmatic prospective randomized trial for low risk DCIS. Our overarching hypothesis is that management of low-risk Ductal Carcinoma in Situ (DCIS) using an AM approach does not yield inferior cancer or quality of life outcomes compared to surgery.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
DCIS;Ductal Carcinoma in Situ
Study phase:
Not applicable
Physician name:
Nina Tamirisa
Department:
Breast Surgical Oncology
For general questions about clinical trials:
1-877-838-7786
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.